The high morbidity/mortality of atherosclerosis is typically precipitated by plaque rupture and consequent thrombosis. However, research on underlying mechanisms and therapeutic approaches is limited by the lack of animal models that reproduce plaque instability observed in humans.
A therosclerosis, a progressive, chronic, inflammatory disease with specific, localized manifestations in the arterial wall, is a major health burden and is predicted to become the leading cause of mortality and morbidity worldwide. 1, 2 Complications of atherosclerosis, such as myocardial infarction (MI), which is the largest single cause of death in developed countries, are caused by inflammation-driven rupture of atherosclerotic plaques. 3 A major hurdle in research on mechanisms of plaque rupture is the lack of appropriate mouse models which exhibit plaque rupture and lesion characteristics of vulnerable, unstable, and thus rupture-prone plaques as found in humans. 4 Such characteristics most importantly include a thin and ruptured fibrous cap, plaque inflammation, neovascularization within the plaque (vasa vasorum), plaque hemorrhage, and intravascular (often occlusive) thrombus formation. 2, 3, [5] [6] [7] In addition, an animal model of plaque instability/rupture should include responsiveness to pharmacological agents known to reduce the risk of plaque rupture in humans. 8, 9 Currently discussed animal models of atherosclerosis typically represent a few but not the full combination of the characteristics seen in human unstable/ruptured plaques. [10] [11] [12] [13] [14] An animal model of plaque rupture that is more representative of human plaque pathology would enable long-awaited further progress in the understanding of plaque rupture and the development of imaging tools to detect vulnerable, rupture-prone atherosclerotic plaques. 15 It is well known that atherosclerotic plaques in humans preferentially occur at vessel bifurcations, where shear stress is low in magnitude and varies significantly over a small distance. 16 Similar predilections for atherosclerosis toward low shear stress areas have been seen in apolipoprotein E-deficient (ApoE −/− ) mice on high-fat diet (HFD). 17 Mechanistic investigations on atherosclerotic plaque development indicate that low shear stress increases the accumulation of macrophages and other inflammatory cells, stimulates overexpression of adhesion molecules and proteases, reduces stabilizing collagen fibers, increases necrotic core volume, causes thinning of fibrous caps, reduces endothelial cell coverage, and worsens lipid accumulation. 18 However, low shear stress alone does not seem to be sufficient to induce plaque rupture. 19 Tensile stress, which indeed is higher by several magnitudes than wall shear stress, seems to be an important determinant responsible for causing a vulnerable atherosclerotic plaque to rupture. 19 There is a high prevalence of plaque rupture in the proximal coronary arteries, where the tensile stress is higher compared with the periphery of the coronary artery system. 3 On the basis of these observations, we used computational fluid dynamics (CFD) to develop an animal model of plaque rupture, which combines low wall shear stress and high tensile stress. We used surgery to introduce a tandem stenosis (TS) in the carotid artery of ApoE −/− mice fed a HFD. Using histology, expression profiling, hierarchical clustering, and quantitative polymerase chain reaction (PCR), as well as pharmacological intervention, we provide evidence that atherosclerotic plaques in this new mouse model resemble human vulnerable plaques. In addition, we present evidence that this mouse model can be used to define and discover novel pathophysiological mechanisms relevant to atherosclerotic plaque rupture in humans.
Methods
A detailed description of methods and materials is provided in the Online Data Supplement.
TS Surgery
At 12 weeks of age, 6 weeks after commencement of HFD, ApoE −/− mice (C57BL/6J background) were anaesthetized by ketamine (100 mg/kg) and xylazine (10 mg/kg) mixture through intraperitoneal injection. An incision was made in the neck and the right common carotid artery was dissected from circumferential connective tissues. A TS with 150 µm (or 450 µm) outer diameters was introduced with the distal point 1 mm from the carotid artery bifurcation and the proximal point 3 mm from the distal stenosis. The stenosis diameter was obtained by placing a 6-0 blue braided polyester fiber suture around the carotid artery together with a 150-or 450-µm needle that was tied to it and later removed. Animals were euthanized at 2, 4, 7, and 11 weeks after surgery.
Statistical Analysis
Quantitative results are expressed as mean±SEM. Comparisons of parameters among 2 groups were made by the unpaired Student t test or Mann-Whitney test. Comparisons of parameters among 4 or 5 groups were made by 1-way ANOVA followed by post hoc analysis using the Newman-Keuls test. Data presented in the Table were evaluated using the Fisher exact test. A P value of <0.05 was considered to be statistically significant.
Results

CFD Predicts Low Shear and High Tensile Stress in a Carotid Artery TS Model
As a first step to developing an animal model of atherosclerosis that results in plaque rupture, we used CFD to predict a carotid stenosis that would generate both low shear and high tensile stress. 20 We simulated pulsatile rather than nonpulsatile, steady blood flow as conventionally done. In CFD modeling the left carotid artery, which is typically plaque free because of high and laminar flow, was used as a control ( Figure 1G ). A model using TS with an outer diameter of 150 µm provided the appropriate wall shear stress during both diastole ( Figure 1A ) and systole ( Figure 1C ). In comparison, a single stenosis of the same outer diameter ( Figure 1B and 1D) exhibited a higher flow rate and higher wall shear stress. Our CFD calculations indicated a reduction in shear stress of ≈27% in the single stenosis model, compared with 74% in the TS model, consistent with reductions in flow in the carotid arteries of mice measured in vivo using an ultrasound Doppler probe ( Figure 1F ). Ultrasound flow measurements revealed a 65±4% flow reduction induced by the TS model, compared with a 26±3.3% reduction induced by single stenosis ( Figure 1I ). A typical flow drop generated by the TS is shown in Figure 1H . A control group of nonconstrictive TS (450 µm outer diameter) was also examined. Flow measurements indicated no change of blood flow (data not shown). Tensile stress in the TS model was highest upstream of the proximal stenosis ( Figure 1E ).
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Mouse TS Model Exhibits Unstable (Segments I and II) and Stable (Segments III and V) Atherosclerotic Plaques, As Well As Nonatherosclerotic Segments (Segment IV)
We next examined whether TS in the right carotid artery of ApoE −/− mice results in unstable atherosclerotic plaques. After HFD of 6 weeks, TS was surgically introduced on the right carotid artery of 12-week-old ApoE −/− mice. Animals were euthanized after a further 7 weeks. To determine how the TS affects development of atherosclerotic lesions, the arterial system in the vicinity of the TS was divided into 5 segments and assessed histologically ( Figure 2A ); vessel segment I typically displayed the characteristics of atherosclerotic plaque instability/rupture, typified by disruption of fibrous caps, intraplaque hemorrhage (IH), and intraluminal thrombosis ( Figure 2B ). Segment I also demonstrated thin caps in the shoulder region (thin cap fibroatheroma) with large necrotic cores ( Figure 2C ). A representative image of the gross anatomy of the TS model indicates the atherosclerotic plaque hemorrhage in segment I ( Figure 2D ). Vessel segment II exhibited a yellow plaque phenotype containing intact fibrous cap with highly cellular plaques and extensive outward remodeling ( Figure 2E ). Vessel segment III displayed a stable atherosclerotic plaque phenotype containing intact and highly cellular fibrous caps and small cholesterol crystals ( Figure 2F ). Vessel segment IV was plaque free and thus representative of a nonatherosclerotic vessel ( Figure 2G ). Vessel segment V, which is composed of the whole aortic arch including the proximal areas of the A. brachiocephalica, A. carotis, and A. subclavia, contained stable atherosclerotic plaques characterized by thick fibrous caps with numerous smooth muscle cells, but no luminal thrombi ( Figure 2H ).
Unstable Plaques in the TS Mouse Atherosclerosis Model Are Associated With Intraplaque Hemorrhage (IH), Large Necrotic Cores, Rupture of Fibrous Caps, and Luminal Thrombosis
As atherosclerotic lesions in segment I of the TS model exhibited features of plaque instability, we characterized plaque progression in this segment at 2, 4, 7, and 11 weeks. Two weeks after TS surgery, segment I contained intact, stable atherosclerotic plaques that were strongly positive for CD68 + macrophages and for vascular cell adhesion molecule-1 expression (Online Figure I) . At 4 weeks, cellular and thick fibrous caps covered most of the lesion, which contained large necrotic cores with cholesterol clefts ( Figure 3A ). At the shoulder region, the cap was less cellular, suggesting susceptibility to plaque rupture ( Figure 3A ). At 7 weeks, evidence of ruptured fibrous caps, IH, and luminal thrombi was found (Figures 2B and 3B). As these lesions progressed, there was evidence of further thinning and disruption of fibrous caps, as well as IH in the necrotic core at 11 weeks ( Figure 3C ; Online Figure II ). Luminal thrombosis is an important characteristic of human plaque rupture, which is absent in other mouse models. 21, 22 To confirm intraluminal thrombosis, we stained for the 2 major components of clots, platelets (CD41), and fibrin. At 7 weeks, positive CD41 ( Figure 3D ) and fibrin ( Figure 3E ) staining were present within intraluminal thrombi in segment I. The fibrillar structure of fibrin can be seen at higher magnification ( Figure 3F ). As IH is a characteristic feature of human plaque rupture, we examined the frequency of IH in lesions at 7 weeks after TS. IH occurred in 50.6% of TS mice (Table) and was macroscopically visible in segment I (Online Figure III) . Importantly, in control mice where a single stenosis (outer diameter, 150 μm) was introduced, a much lower frequency (14.2%) of IH was observed (Table) . With the outer diameter of the vessel remaining at 450 μm, none of the mice exhibited IH, indicating that the suture itself does not induce IH. IH cannot be seen in the sham-operated mice, indicating the surgical procedure does not induce IH on its own (Online Figure IV) . Among the 75 animals, 24 animals were found with a clearly visible disruption of the cap (Table) . In addition, platelet (CD41) and fibrin staining within the atherosclerotic plaque could only be detected in unstable atherosclerotic plaques in segment I, but not in other segments, with an average of 8.5% fibrin-positive staining of the total plaque area (n=6).
Total ligation of the right carotid artery has previously been proposed as a model of unstable atherosclerosis. 23 To allow a direct comparison to the TS model, we induced a total ligation of the right carotid artery and examined atherosclerotic plaques at 7 weeks. Low levels of lipid content and low abundance of CD68 + macrophages were observed in the ligated carotid artery. Moreover, plaques displayed strong collagen staining (Trichrome) and extensive neointimal hyperplasia (Online Figure  V) . In contrast to our TS model, total ligation did not induce the development of necrotic cores or formation of fibrous caps.
Identification of Neo Vasa Vasorum and Intraplaque Microvessel
The neo vasa vasorum in adventitial tissue of vulnerable, unstable human atherosclerotic plaques contribute to the development of complex lesions by acting as a conduit for inflammatory cells and have also been associated with IH. 24 Consequently, we examined whether vasa vasorum can be detected within vulnerable plaques in our mouse model. Vasa vasorum were readily apparent in segment I, even macroscopically (Online Figure VIA) . Expression of the endothelial cell marker CD31 confirmed the presence of neo vasa vasorum within the tunica adventitia of atherosclerotic lesions (Online Figure VIB) . Atherosclerotic lesions were also highly vascularized in the region adjacent to the tunica media (Online Figure VIC) . These intraplaque microvessels consist of a single layer of endothelial cells (Online Figure VID) and were often adjacent to positive iron staining, reflecting old hemorrhage remnants (Online Figure VIE ). 25 The average vessel density is 3 neovessels per 100 000 µm 2 total plaque area in segment I at the 7-week time point (n=10 sections from each mouse, 10 mice were used and quantified). Importantly, intraplaque neovessels could not be found in segments II to V. Thus, our unique TS animal model presents neo vessel formation in both the tunica adventitia and within the atherosclerotic plaques, which strongly reflects characteristics observed in human unstable plaques.
Pathological Description of Vessel Segments I, II, III, and V of the TS Model
To understand the pathology of the TS model further, we analyzed plaque composition in the 5 segments at 7 weeks after TS surgery. Segment I (unstable) contained ≈80% less intimal collagen compared with segments III (stable) and V (stable; Figure 4A ; Online Figure VIIA ). Segment I also showed increased intimal CD31 expression compared with segments III and V, indicating intraplaque microvessel formation ( Figure 4B ; Online Figure VIIB ). Vessel segment I comprised 50% more lipid compared with segment II (P<0.01) and 60% more lipid compared with segment III (P<0.001), whereas there was no difference in lipid content between segments I and V ( Figure 4C ; Online Figure VIIC ). Furthermore, monocyte and macrophage marker positive cells were significantly higher in segment I compared with segments II (74%), III (90%), and V (55%; Figure 4E ; Online Figure VIIE) . Interestingly, the number of CD45 + and CD3 + positive cells, representing all leukocytes and T cells, respectively, was significantly higher in segment I compared with segments III and V ( Figure 4F and 4G). There was no difference in intimal smooth muscle cells, between the 5 vessel segments ( Figure 4D ; Online Figure  VIID ). Immunostaining with an IgG isotype control confirmed the specificity of the antibodies used (Online Figure VIIE , inset). Finally, unstable plaques in segment I exhibited thin cap fibroatheroma and a larger necrotic core (42%, 90%, and 65% increased necrotic core compared with segments II, III, and V, respectively; Figure 4H ) and a relatively thin fibrous cap (35%, 52%, and 49% decrease in cap thickness compared with segments II, III, and V, respectively; Figure 4I ). These data suggest that segment I represents an unstable atherosclerotic plaque reflecting the pathology of vulnerable plaques in humans.
Treatment With Atorvastatin Reduces the Incidence of IH
In humans, statin therapy has been shown to reduce the incidence of IH. 26 Hence, to investigate whether the unstable plaques in our TS mouse model also respond to pharmacological intervention, we evaluated the effects of statin therapy (atorvastatin 10 mg/kg per day for 7 weeks) 27 on IH induced by TS. High-density lipoprotein, low-density lipoprotein, or total cholesterol levels did not change in mice treated with atorvastatin (Online Table I ). However, the incidence of spontaneous IH in segment I was substantially reduced from 50.6% to 12.5% (P<0.05; Fisher exact test; Table) . To visualize the extent of IH, longitudinal sectioning of the brachiocephalic artery to the common carotid artery proximal to the first suture was performed and serial images were merged for viewing across the entire arterial segment ( Figure 5A ). Treatment with atorvastatin preserved the vessel lumen ( Figure 5B ), but there was no difference in total plaque area ( Figure 5C ), lipid content ( Figure 5D ), or foam cell accumulation (data not shown). Interestingly, atorvastatin treatment did increase collagen content ( Figure 5E ), indicating an increase in plaque stability.
To demonstrate further that statin treatment results in plaquestabilizing effects in our TS mouse model, we examined 2 markers with a documented role in human plaque instability, monocyte chemoattractant protein-1 (MCP-1), and ubiquitin. [28] [29] [30] MCP-1 expression was significantly reduced by atorvastatin treatment (Figure 5F -5H). Ubiquitin was strongly expressed in the plaque area of segment I of the TS model, and this expression was significantly reduced by atorvastatin ( Figure 5I-5K ).
Gene Expression Profiling for Characterization of the Unstable Atherosclerotic Plaque and Identification of Genes Relevant to the Pathophysiology of Plaque Instability
Having established that the TS model shares many histopathologic features of human atherosclerosis, particularly Morphometric and immunohistological analysis of collagen, CD31, lipid, smooth muscle cells (SMCs), MOMA-2, CD45, CD3, necrotic core, and relative cap thickness. A, The rupture-prone segment I has significantly less intimal collagen compared with the areas of stable atherosclerotic plaques (segments III and V). B, Segment I is highly vascularized compared with segments II, III, and V, as reflected by CD31 staining. C, The percentage of intimal lipid staining in segment I is significantly higher compared with segments II and III, but not to segment V. D, No significant difference in SMC content between the different vessel areas. E, Segment I contains more inflammatory macrophages as compared with segments II, III, and V, as determined by MOMA-2 staining. Segment I also contains significantly higher CD45 (F) and CD3 positive cells (G). Segment I contains the largest necrotic cores (defined by acellular area and cholesterol crystal area divided by neointimal area) compared with other fragments (H). Segment I exhibits the thinnest and smallest caps (as defined by relative cap thickness via the ratio of the cap thickness at the shoulder and midplaque region divided by maximal intimal cross-sectional thickness (I). n=12 for each group (*P<0.05; **P<0.01; and ***P<0.001). July 19, 2013 the pathology of plaque instability, we used this model to investigate molecular characteristics associated with stable and unstable atherosclerotic plaques. We investigated gene expression in the various plaque phenotypes displayed in vessel segments I to V at 7 weeks after TS surgery. To obtain sufficient mRNA for each segment, we pooled tissue from 20 mice. As a repeat measurement, this was conducted a total of 3× (3 analyses per segment with 20 mice per analysis). Extracted RNA was processed and analyzed for gene expression using the Illumina mouse WG-6 beadchip microarray as described previously. 31 To assess the relatedness between the repeats of the same anatomic location, and thus to compare stable, unstable atherosclerotic segments and nonatherosclerotic segments with each other, we plotted the principal component analysis of the sample profiles in an unsupervised fashion, across all genes. The principal component analysis plot clearly shows that samples pooled from identical segments were most closely related to each other, providing confidence of sample quality in each repeat ( Figure 6A ). Next, we performed an ANOVA, with the aim of identifying genes that were differentially expressed between stable and unstable plaques. Hierarchical clustering of genes that were differentially expressed >2-fold at P<0.05 significance illustrated coordinate expression patterns for each pathological sample group ( Figure 6B) . Several genes previously shown to be associated with plaque instability were upregulated in vessel segment I. These included MCP-1, interleukin Iβ, transforming growth factor-β, matrix metalloproteinase (MMP) 9, MMP-12, platelet-derived growth factor β, and F4/80 ( Figure 6C-6I ). These microarray data were confirmed by quantitative real-time PCR, demonstrating that vessel segment I had increased expression of MCP-1 (88×), interleukin Iβ (106×), transforming growth factor-β (7.8×), platelet-derived growth factor β (7.7×), MMP-9 (2.3×), MMP-12 (119×), and F4/80 (14×) when normalized to nonatherosclerotic segment IV. This demonstrates that in vessel segment I, which is prone to plaque rupture, a high degree of inflammation and protease activity is present ( Figure 6C -6I, bottom).
Expression Analysis of miRs Identifies Specific Expression Profiles for Unstable Plaques (Segments I and II) and Allows the Discovery of Novel Pathophysiologically/Therapeutically Relevant miRs
MicroRNAs (miRs) are increasingly recognized as important mediators of cardiovascular pathologies. 32, 33 MiR microarrays were used to demonstrate further the feasibility of our TS mouse model in discriminating between unstable and stable plaques, as well as to demonstrate the potential of the model as a discovery tool. Expression levels of miRs were determined in tissue from vessel segments I, II, IV, and V using an Illumina microarray. Hierarchical clustering of miRs that were differentially expressed >2-fold at a significance level of P<0.05 between any of the 4 investigated segments illustrated coordinate expression patterns, providing a strong discrimination between segments I and II compared with segments IV and V ( Figure 7A ). These data further support the suitability of the current mouse model to represent different plaque pathologies in different vessel segments. Notably, the miR expression profiles of segments I and II cluster close together ( Figure 7A ), as seen with the mRNA expression profiling ( Figure 6A and 6B) .
Given the strong relationship in expression profiles between segments I and II and segments IV and V, these segments were combined to represent unstable (segments I and II) or stable (segments IV and V) plaques (Online Table II ). Subsequent analysis identified 30 miRs whose expression significantly differed between the 2 groups. Seven of these miRs, miR-138*, 142-3p, 298, 322, 335-3p, 450a, and 503* were chosen for validation using quantitative reverse transcriptase-PCR ( Figure 7B-7H) . Five of these miRs demonstrated an upregulation in segment I (unstable) when compared with segment V (stable). Among these 5 miRs, miR-322 was chosen for further exemplary analysis on the basis of its upregulation in segment I compared with segment V ( Figure 7E ). In addition, network analysis performed with GeneGo on predicted miR-322 target genes further supported the involvement of miR-322 in the formation of atherosclerosis, by targeting several relevant genes, such as FGF-7, CX3CL1, FGF1, TNFSF13, APJ, and LAMP2 (Online Figure VIII) . To confirm the relationship between miR-322 and FGF-7, miR-322 was transiently silenced in RAW 264.7 macrophages using anti-miR-322. This resulted in a significant increase in FGF-7 expression ( Figure 7I ). In addition, the expression of anti-inflammatory cytokine IL-10 was significantly upregulated ( Figure 7J ) and the expression of proinflammatory cytokine IL-6 downregulated in response to miR-322 inhibition ( Figure 7K ). These data demonstrate the feasibility of the TS model as a tool for miR discovery and provide a unique and extensive list of further miRs to be studied in atherosclerosis (Online Table II ).
Cross Analysis of mRNA and miR Microarray
Further analysis of the microarray expression data was performed using 2 software tools (GeneGo and Ingenuity Pathway Analysis). Segments I and II, as well as segments III, IV, and V, were grouped together to represent stable (segments III, IV, and V) or unstable plagues (segments I and II). Ingenuity Pathway Analysis clustered differentially expressed genes identified by mRNA microarrays into the main ontologies: inflammatory response, inflammatory disease, as well as cardiovascular system development and function (Online Table III ). The same gene ontologies are significantly enriched when analyzing differentially expressed genes that are predicted target genes of the identified miRs (Online Table IV ). A similar gene ontology profile was obtained when performing the pathway analysis using GeneGo, which demonstrated a strong overrepresentation of inflammatory response and immune response pathways in the differentially expressed genes and experimentally validated predicted miR target genes (Online Figure IXA) , as well as in the differentially expressed genes, which overlap with predicted miR target genes (Online Figure IXB) . Thus, microarray profiling of mRNA and miR can be used to define gene signatures that can differentiate between stable and unstable atherosclerosis in this model system. Furthermore, cross analysis of the mRNA and miR microarray data identifies gene signatures representing conserved ontologies that are associated with the atherosclerotic process, including inflammatory response and cardiovascular system and development signatures.
Overall, 243 of the predicted miR target genes overlap with differentially expressed genes identified in the mRNA microarray. Of these 243 overlapping genes, 118 show an inverse relationship with their corresponding miR. MiRs that show significant overrepresentation of their predicted, differentially expressed target genes include miR-322-5p, miR-298, miR-351, miR-138, miR-34c, or miR-503, with 47, 45, 43, 40, 34, or 23 predicted targets, respectively. These miRs are particularly attractive for further studies toward the therapeutic use of miRs in plaque stabilization. , which are up-or downregulated in unstable atherosclerotic plaques and as an example points to a proinflammatory role of miR-322. A, MiR expression levels were determined in tissue from vessel segments I and II vs IV and V using the Illumina microarray beadchip. Thirty miRs differed significantly in their expression between segments IV and V and segments I and II. Heat map of these miRs, which were >2-fold differentially expressed at P<0.05 significance, illustrate a coordinate expression patterns for each vessel segment. MiR-138* (B), miR-142-3p (C), miR-298 (D), miR-322 (E), miR-335-3p (F), miR-450a (G), and miR-503* (H) were chosen for validation in qRT-PCR. MiR-322 was selected for further studies: (I) RAW 246.7 mouse macrophages given anti-miR-322 demonstrated the strong regulation of the expression of the target gene FGF-7 by miR-322. J, Inhibition of miR-322 increases anti-inflammatory cytokine interleukin 10 (IL-10) production but inhibits (K) proinflammatory interleukin 6 (IL-6) cytokine generation (n=3; *P<0.05; **P<0.01; and ***P<0.001 compared with RAW cells only as control). All data are normalized to 18S and expressed as mean±SEM. July 19, 2013
TS Mouse Model as Discovery Tool: Identification of ADAMTS4 As a Pathogenic Factor in Mouse and Human Plaque Instability
To demonstrate further the feasibility of the TS model as a discovery tool for the identification of genes/proteins that play an important role in plaque instability, we selected 1 gene of the 28 that were upregulated by >5-fold in the Illumina microarray (Online Table V ). The Illumina microarray indicated that a disintegrin and metalloprotease with thrombospondin motifs 4 (ADAMTS4) was significantly upregulated in segment I in comparison with segment V (Online Figure XA) . This upregulation was confirmed by quantitative reverse transcriptase-PCR (Online Figure XB) . Immunohistochemistry localized ADAMTS4 to the fibrous cap of plaques found in segment I (Online Figure XC) . The expression of ADAMTS4 was lower in plaques of the aortic arch (segment V; Online Figure XD) . Next, we examined human plaques collected from patients who underwent carotid endarterectomy. We found that ADAMSTS4 was also expressed in human advanced atherosclerotic plaques (Online Figure XE) . Interestingly, human early fatty streak lesions show no expression of ADAMTS4 (Online Figure  XF) , indicating ADAMTS4 as a marker of advanced unstable plaques. These data indicate that novel mechanisms and potential therapeutic targets relevant for plaque instability in humans can be identified using our mouse TS atherosclerosis model. This encourages the use of our unique animal model as a discovery tool for research on human plaque instability. The genes identified to be upregulated in unstable plaques (Online Table  V ) provide a unique basis for numerous studies toward the role of these genes in the pathogenesis of plaque rupture, as well as their suitability as potential targets for plaque stabilization.
Discussion
Rupture of atherosclerotic plaques is the major cause of mortality and morbidity of atherosclerosis in humans. For a better understanding of the underlying pathophysiology of plaque rupture, particularly for the development of drugs, which can ultimately prevent MI or stroke, an animal model is highly sought-after. 4 By focusing on hemodynamic considerations, we have designed and extensively characterized a mouse model of atherosclerosis that reflects the major characteristics of human plaque instability/rupture. Specifically, the atherosclerotic plaques of this model exhibit (1) thin and disrupted fibrous caps, (2) necrotic cores, (3) accumulation of lipids, (4) accumulation of macrophages/foam cells, (5) presence of platelets and fibrin, (6) IH, which often extended into the necrotic core, (7) intravascular thrombosis, (8) neovascularization within the plaque (notably associated with IH), (9) vascular remodeling (eccentric growth of the atheroma), (10) specific expression patterns of genes relevant to inflammation and plaque instability that strongly differentiate among unstable, stable plaques, and nonatherosclerotic arteries, (11) miR expression patterns that characterize unstable atherosclerotic plaques, (12) hemodynamic characteristics that drive and localize plaque development and instability, and (13) responsiveness to statin therapy, resulting in plaque stabilization. In addition, to demonstrate that our TS mouse model reflects the characteristics of unstable/ruptured plaques in humans, we provide proof of principle that this model can be used as a discovery tool toward a better understanding of human atherosclerotic disease and its complications.
Although the need for an animal model that reflects human plaque rupture and plaque instability is widely recognized, major controversy exists as to whether published animal models adequately reflect human plaque instability. 23, [34] [35] [36] [37] [38] Rosenfeld et al 12 highlighted that atherosclerotic lesions in brachiocephalic arteries of mice progress from fatty streaks to advanced atheromas, characterized by highly acellular plaques. However, IHs were only present in ≤0.6% of mice investigated (>120 mice). The authors further demonstrated that this type of plaque disruption did not lead to thrombosis. Rosenfeld et al, 12 therefore, concluded that this mouse model does not reflect human plaque instability. Jackson et al 8 introduced one of the best characterized animal models focusing on the arteria brachiocephalica in ApoE −/− mice fed with HFD. Layers of buried/disrupted fibrous caps and erythrocyte accumulation, as well as fibrin staining, were described as an indication of previous ruptures and healing processes. 8, 22 The major limitations of this model are the absence of luminal thrombosis, limited plaque inflammation, absence of vasa vasora, and the mixed genetic background of the mice used (C57BL/6 and 129). 22 Cheng et al 17 reported the use of a perivascular cast device that allows modifying shear stress in the carotid artery of mice. The authors demonstrated that low shear stress causes atherosclerotic plaques to exhibit features of a vulnerable phenotype. 18 However, the cast itself may cause an artificial inflammatory reaction and pivotal features of human vulnerable plaque development, such as the disruption of fibrous caps, necrotic cores, or any luminal thrombosis, are missing. von der Thüsen et al 10 developed an interesting but elaborate model that combines the application of a perivascular silastic carotid collar placement, the intravascular injection of a recombinant adenovirus carrying a p53 transgene, and the application of a vasopressor to achieve plaque rupture in 40% of ApoE −/− mice. This model by combining the induction of inflammation, apoptosis, and high tensile stress has provided major pathophysiological insights, but is not suitable as a high throughput animal model. 10 Although representing important features of plaque instability, it has also been discussed as not fully representing human atherosclerosis. 39 Notably, some mouse models were developed with a focus on individual features of plaque instability. For example, Sasaki et al 23 used a total vessel ligation to induce short-term thrombosis on the basis of blood stasis to reflect luminal thrombosis as part of human plaque development. 35 Overall, the strong medical need for an animal model of plaque instability has resulted in the development of various mouse models, but none is broadly used or has been generally accepted to represent the pathology of human vulnerable atherosclerotic lesions fully. 22 Only a few mouse models of atherosclerosis demonstrate advanced disease in the coronary arteries. [40] [41] [42] These mouse models with genetic deficiencies (scavenger receptor class B type I and low-density lipoprotein receptor double knockout mice, V-akt thymoma viral oncogene homolog 1, and apolipoprotein E double knockout mice) have attracted major interest, particularly as they are associated with MI and premature death. As both, histological characteristics of human vulnerable plaques and advanced occlusive coronary artery disease have been seen in these mice, it remains to be determined and is of major interest whether plaque rupture or progressive vessel occlusion is the underlying mechanism for MI and death.
In addition to thrombosis, plaque hemorrhage is the most prominent driving force of instability in human atherosclerotic plaques. The accumulation of cholesterol originating from erythrocyte membranes causes enlargement of the necrotic core, stimulates macrophage infiltration, and triggers further characteristics of plaque instability. 10, 17, 25 The fact that plaque hemorrhage is rare or has typically not been described in animal models of atherosclerosis to date has questioned the relevance of many models for the investigation of mechanisms in human atherosclerosis. In contrast, in our TS model, the specific detection of plaque hemorrhage in the vessel segment of plaque instability and the strong reduction of its prevalence with atorvastatin treatment indicate that this mouse model reflects human plaque pathology.
Adventitial vasa vasorum exhibit a strong association with atherosclerotic plaque development. Administration of the angiogenesis inhibitor, angiostatin, suppresses lesion growth. 43 Although a relationship exists between the function of neovessels and manifestation of atherosclerosis, its nature remains unclear. In our TS model, we observed neovascularization close to the internal elastic lamina, often associated with plaque hemorrhage, and interestingly only in unstable plaques in segment I, not in other segments. This association reflects human plaque pathology and has not been described in other mouse models of atherosclerosis. Neovessels are typically formed by endothelial cells without pericyte support, which is thought to explain their leaky nature. Again the finding of neovascularization of plaques further supports the suitability of our plaque rupture model for studies of human plaque pathology.
The plaque-stabilizing effects seen with atorvastatin, in particular the significant reduction of IH further supports the unique translational validity of TS model. Atorvastatin reduced the expression of MCP-1 and ubiquitin, proteins that are highly expressed in unstable human atherosclerotic plaques. 44 Furthermore, the detected increase in collagen expression is also a hallmark of statins' stabilizing effects on human atherosclerosis. 45 Finally, the clinically documented reduction of cardiovascular events in patients on statin therapy may be well reflected in our finding of reduced incidence of IH. 46 The ability to test pharmaceutical reagents for their effects on plaque stability/rupture opens up a wide range of applications using our TS animal model and its translation to human plaque pathology.
The use of mRNA microarray technology has provided major advances and information on plaque rupture at 3 different levels. First, the significant differences of overall gene expression between the various vessel segments provide strong support that the biology of stable and unstable atherosclerotic plaques is distinct and our animal model can be used to distinguish these differences. Interestingly, hierarchical clustering showed a strong similarity between segments I and II, indicating that the main underlying pathogenic mechanisms of plaque instability, such as inflammation, are present in both segments. However, different hemodynamic conditions seem to define differences in plaque morphology as seen between segments I and II. This supports our initial hypothesis that plaque instability is determined by specific hemodynamic conditions, and it strengthens the rationale of using a TS to create a mouse model of plaque instability. Second, mRNA expression assessed using Illumina chip technology and confirmed by quantitative reverse transcriptase-PCR demonstrated a significant upregulation of genes previously associated with human plaque instability, including MCP-1, interleukin Iβ, transforming growth factor-β, platelet-derived growth factor β, MMP-9, MMP-12, and F4/80. 47 MCP-1 has been postulated to be a direct mediator of plaque instability by inducing the expression of metalloproteinases, adhesion molecules, and cytokines. Inhibition of MCP-1 has previously been shown to induce stabilization of atherosclerotic plaques and reduce hyperplasia after balloon injury in animal models. 48, 49 Similar associations have been seen in humans. 28 Furthermore, MMP-9 and 12 have been directly associated with atherosclerotic plaque development, including instability in both knockout/transgenic animals and humans. 50, 51 Finally, our expression profiling studies established the TS model as a unique discovery tool. We have identified a unique list of genes that promise to be relevant to plaque instability/rupture (Online Table V ). This opens up the opportunity for numerous studies to investigate the role of these genes in the pathogenesis of plaque rupture and their suitability as potential therapeutic targets for plaque stabilization.
One of the findings originating from our gene expression profiling is the upregulation of ADAMTS4 in ruptured carotid atherosclerotic plaques of mice and the direct demonstration of its relevance for human carotid plaques. Interestingly, ADAMTS4 was located in the fibrous cap adjacent to the areas of plaque rupture in the mouse. ADAMTS4 is a member of the metalloproteinase family, which includes secreted proteinases that bind to and cleave extracellular matrix components. Degradation of extracellular matrix, such as versican and collagen, has received much attention in regards to promoting plaque instability. 52 ADAMTS4 cleaves versican and has been recently identified in human atherosclerotic plaques. 53 Notably, plasma ADAMTS4 has been found to be increased in patients with acute MI. 54 Further work is warranted to address the detailed role of ADAMTS4 systematically in plaque formation and stability.
Our TS model offers the unique opportunity to identify miRs involved in plaque rupture. Although the functions of these miRs are yet to be fully elucidated, previous reports demonstrated that, for example, miR-138 and miR-142 are upregulated in blood of stroke patients. 55 MiR-322 and miR-335 have been demonstrated to promote adipogenesis by inhibiting the Wnt signaling pathway in 3T3-L1 cells. 56 This pathway demonstrates a profound involvement in regulating inflammation, foam cell accumulation, pathological angiogenesis, and atherosclerosis, roles that are also consistent with our findings. In addition, miR-322 regulates several genes involved in atherosclerosis, such as FGF-7, CX3CL1, FGF1, TNFSF13, APJ, and LAMP2. A network map of these genes, as well as other experimentally validated miR-322 target genes that were differentially expressed in unstable and stable plaque as identified by mRNA microarray, is illustrated in Online Figure VIII.  July 19, 2013 The list of miRs (Online Table II) found to be upregulated in unstable plaques provides the basis for attractive future studies aiming to define the pathophysiological role of these miRs in plaque instability/rupture, and the primary target genes through which these effects are mediated. Most intriguing is the possibility to use the recently established, highly promising therapeutic approach of antagonizing miRs 33, 57 toward plaque stabilization and ultimately the prevention of MI and stroke.
A combined analysis of miR and mRNA confirms the induction of different atherosclerotic phenotypes after TS surgery and identified several novel genes and miRs differentially and inversely expressed in unstable plaques, which are potentially suitable for therapeutic approaches toward plaque stabilization. In addition, pathway analysis with Ingenuity Pathway Analysis or GeneGo revealed a significant overrepresentation of differentially expressed genes or miR target genes involved in the inflammatory response and immune response, and overall showed a strong correlation between mRNA and miR datasets, indicating the validity of our data sets.
In conclusion, we developed and characterized a novel animal model of atherosclerosis that resembles atherosclerotic plaque development seen in humans. This unique animal model is a promising tool to study mechanisms of plaque instability/rupture and to identify therapeutic targets with the ultimate aim to prevent atherosclerotic plaque rupture.
What New Information Does This Article Contribute?
• Surgically applied tandem stenosis of the carotid artery of apolipoprotein E-deficient mice creates a combination of low shear stress and high tensile stress, leading to unstable, vulnerable atherosclerotic plaque development, including plaque rupture, which closely resembles human plaque instability. • The tandem stenosis model represents a unique discovery platform for identification of clinically relevant pathogenic factors, including microRNAs, and for the development and testing of potential therapeutics that can prevent plaque instability/rupture.
Although the major complication of atherosclerosis is plaque rupture, there is no animal model that fully reflects final stages of human plaque instability and rupture. On the basis of computational fluid dynamics, we used a surgically applied tandem stenosis to create a low shear/high tensile stress-defined vessel segment in the carotid artery of apolipoprotein E-deficient mice. This facilitates the formation of unstable plaques with characteristics that reflect human plaque pathology, including plaque rupture. Profiling of unstable plaques from this model led to the identification of several pathways, genes and microRNAs potentially involved in human plaque instability. Furthermore, as demonstrated with atorvastatin, the novel model could also be used for drug testing. This mouse model of plaque instability/rupture represents a unique discovery tool that allows for identification of pathogenic factors and development and testing of drugs, ultimately facilitating the development of new strategies for the treatment of plaque instability and prevention of plaque rupture.
Novelty and Significance
